Capricor Therapeutics (CAPR) EBIT Margin Growth (5y) (2016 - 2024)
Capricor Therapeutics (CAPR) EBIT Margin Growth (5y) (2016 - 2024) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
| 1 |
Alterity Therapeutics |
723,416.35 Bn |
723,416.32 Bn |
- |
| 2 |
Belite Bio |
57,340.00 Bn |
57,340.00 Bn |
- |
| 3 |
Quantum Biopharma |
19,125.08 Bn |
19,125.08 Bn |
- |
| 4 |
Legend Biotech |
3,262.00 Bn |
3,261.71 Bn |
242.10 Mn |
| 5 |
Akari Therapeutics |
1,789.67 Bn |
1,789.67 Bn |
- |
| 6 |
Evaxion A |
1,480.39 Bn |
1,480.37 Bn |
- |
| 7 |
Psyence Biomedical |
241.78 Bn |
241.78 Bn |
- |
| 8 |
Vertex Pharmaceuticals |
113.54 Bn |
106.29 Bn |
2.59 Bn |
| 9 |
Abivax |
94.26 Bn |
94.26 Bn |
- |
| 10 |
Capricor Therapeutics |
1.53 Bn |
1.26 Bn |
- |
| Date | Value |
|---|
| Dec 31, 2024 |
90,479.00 |
| Sep 30, 2024 |
57,043.00 |
| Jun 30, 2024 |
21,153.00 |
| Mar 31, 2024 |
100,672.00 |
| Dec 31, 2023 |
49,952.00 |
| Sep 30, 2023 |
179,185.00 |
| Jun 30, 2023 |
83,279.00 |
| Mar 31, 2023 |
64,735.00 |
| Dec 31, 2022 |
-15,087.00 |
| Sep 30, 2022 |
43,499.00 |
| Jun 30, 2021 |
-198,470.00 |
| Mar 31, 2021 |
-1.22 Mn |
| Dec 31, 2020 |
-710,520.00 |
| Sep 30, 2020 |
-2.30 Mn |
| Jun 30, 2020 |
-675,765.00 |
| Mar 31, 2020 |
-80,713.00 |
| Dec 31, 2019 |
-74,239.00 |
| Sep 30, 2019 |
-100,310.00 |
| Jun 30, 2019 |
-36,127.00 |
| Mar 31, 2019 |
-99,558.00 |
